nifurtimox 120 MG Oral Tablet [Lampit]
- RxCUI
- 2397994
- RxNorm name
- nifurtimox 120 MG Oral Tablet [Lampit]
- Display name
- nifurtimox 120 MG Oral Tablet [Lampit]
- Full name
- nifurtimox 120 MG Oral Tablet [Lampit]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:08
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LAMPIT | NIFURTIMOX | Bayer HealthCare Pharmaceuticals Inc. | 90d09714-a8b1-4696-8ada-f99dc54d0721 | 2026-03-03 | Warnings, Adverse reactions | 2397994 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 90d09714-a8b1-4696-8ada-f99dc54d0721 | nifurtimox 120 MG Oral Tablet [Lampit] | SBD | 9 | These highlights do not include all the information needed to use LAMPIT safely and effectively. See full prescribing information for LAMPIT. LAMPIT (nifurtimox) tablets, for oral use Initial U.S. Approval: 2020 | 20260303 |
| 90d09714-a8b1-4696-8ada-f99dc54d0721 | Lampit 120 MG Oral Tablet | PSN | 9 | These highlights do not include all the information needed to use LAMPIT safely and effectively. See full prescribing information for LAMPIT. LAMPIT (nifurtimox) tablets, for oral use Initial U.S. Approval: 2020 | 20260303 |
| 90d09714-a8b1-4696-8ada-f99dc54d0721 | Lampit 120 MG Oral Tablet | SY | 9 | These highlights do not include all the information needed to use LAMPIT safely and effectively. See full prescribing information for LAMPIT. LAMPIT (nifurtimox) tablets, for oral use Initial U.S. Approval: 2020 | 20260303 |